Articles From: UPDATE: Jim Chanos downbeat on Exxon, Caterpillar, Intel to UPDATE: Investors are looking at the wrong oil prices


2015/1/16
Legendary short seller Jim Chanos on Friday said he sees trouble ahead for big multinational energy companies, mentioning in particular Exxon Mobil Corp.
Sign-up for UPDATE: Jim Chanos downbeat on Exxon, Caterpillar, Intel investment picks
2015/1/16
VENLO, The Netherlands , January 16, 2015 /PRNewswire/ -- QIAGEN N.V. (Nasdaq: QGEN) (Frankfurt: QIA) plans to release its report on results for the fourth quarter and full year 2014 on Wednesday, January 28 , at 22:00 Central European Time (CET) / 16:00 Eastern Time (ET). Also as previously announced, a conference call is planned for Thursday, January 29 , at 15:30 CET / 9:30 ET that will include remarks by Peer M.
Sign-up for QIAGEN N.V. to Report Fourth Quarter and Full-Year 2014 Results investment picks
2015/1/16
OCI Resources LP (the "Partnership") (NYSE: OCIR) announced today the approval, on January 15, 2015, of an increase to its quarterly distribution by the board of directors of its general partner.
Sign-up for OCI Resources LP Increases Quarterly Cash Distribution investment picks
2015/1/16
By Gregor Stuart Hunter Move would affect Chinese Internet sector, including Alibaba MSCI will allow shares of companies trading outside their home markets to enter their native country indexes, a move which is likely to funnel billions of dollars in capital flows toward companies that lack a domestic listing, such as Alibaba (BABA) . But the index provider declined to include Russian companies among those which would be assessed for entry, citing investor concerns.
Sign-up for MSCI paves way for overseas listings to enter indexes investment picks
2015/1/16
The Goldman Sachs Group, Inc. (NYSE: GS) today reported net revenues of $34.53 billion and net earnings of $8.48 billion for the year ended December 31, 2014.
Sign-up for Goldman Sachs Reports Earnings Per Common Share of $17.07 for 2014 investment picks
2015/1/16
HOUSTON, Jan.
Sign-up for Integrated Electrical Services Announces Leadership Changes investment picks
2015/1/16
Equity Commonwealth (NYSE: EQC) today announced that its Board of Trustees declared dividends on the Company’s Series D and E Preferred Shares.
Sign-up for Equity Commonwealth Declares Series D and E Preferred Dividends investment picks
2015/1/16
ST. LOUIS, Jan.
Sign-up for LMI Aerospace, Inc. Announces New Addition to Executive Team investment picks
2015/1/16
Earnings per share of $0.47 for the fourth quarter 2014, up 9 percent from the fourth quarter 2013 Earnings per share of $1.94 for the full year 2014, up 24 percent from the prior year CHICAGO , Jan.
Sign-up for PrivateBancorp Reports Fourth Quarter and Full Year 2014 Earnings investment picks
2015/1/16
By James Glynn and Lucy Cramer FXCM's equity wiped out A major U.S. currency broker said it suffered "significant losses" that wiped out its equity, and a New Zealand foreign-exchange trading house failed, as the fallout from the decision by the Swiss National Bank to cease capping the nation's currency spread across the world.
Sign-up for UPDATE: Swiss move hits major U.S. broker, runs New Zealand trading house out of business investment picks
2015/1/16
JOHANNESBURG , January 16, 2015 /PRNewswire/ -- Journalists and other readers should disregard the news release "South Deep Fatality", issued at 10:28 GMT , 16 Jan 2015.
Sign-up for /DISREGARD RELEASE: Gold Fields Limited, South Africa/ investment picks
2015/1/16
CLEVELAND , Jan.
Sign-up for TransDigm First Quarter Earnings Report and Conference Call Set for Tuesday, January 27, 2015 investment picks
2015/1/16
By Barbara Kollmeyer and Sara Sjolin, MarketWatch Fallout from Swiss move could keep coming, FXCM sinks LONDON (MarketWatch) -- U.S. stock futures on Friday pointed to a lower open for Wall Street, extending Swiss-driven losses from the previous session ahead of inflation data and a closely watched earnings report from Goldman Sachs.
Sign-up for UPDATE: U.S. stocks: Futures pitch lower, with Goldman, inflation data ahead investment picks
2015/1/16
TSX: IMG NYSE: IAG All monetary amounts are expressed in U.S. dollars, unless otherwise indicated.
Sign-up for IAMGOLD cleared to complete sale of Niobec for a total consideration of US$530 million investment picks
2015/1/16
Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that a paper, titled “PI3K/mTOR dual inhibitor VS-5584 preferentially targets cancer stem cells,” has been published in Cancer Research , a peer-reviewed journal of the American Association for Cancer Research (AACR). The paper discusses results from preclinical research evaluating VS-5584, a highly potent, selective small molecule inhibitor of mTORC1/2 and Class I PI3K kinases, which preferentially targets cancer stem cells (CSCs) in vitro and in vivo .
Sign-up for Verastem Announces Publication of Scientific Data for VS-5584 in Cancer Research investment picks
2015/1/16
The Wet Seal, Inc. (Nasdaq: WTSL), a specialty retailer to young women, today announced that it has filed voluntary petitions for relief under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”) on January 15, 2015.
Sign-up for Wet Seal Files for Chapter 11 Bankruptcy Protection investment picks
2015/1/16
Enanta Announces European Commission Grants Marketing Authorizations for AbbVie’s VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA® (dasabuvir tablets) for the Treatment of Genotypes 1 and 4 Chronic Hepatitis C Virus Enanta Pharmaceuticals, Inc., (NASDAQ:ENTA) a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that the European Commission has granted marketing authorizations for AbbVie’s VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA® (dasabuvir tablets) 1,2 with or without ribavirin (RBV) for the treatment of patients with genotype 1 (GT1) chronic hepatitis C virus (HCV) infection, including those with compensated liver cirrhosis, HIV-1 co-infection, patients on opioid substitution therapy and liver transplant recipients.
Sign-up for Enanta Announces European Commission Grants Marketing Authorizations for AbbVie’s VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets)... investment picks
2015/1/16
NORTH CHICAGO, Ill.
Sign-up for AbbVie to Host Fourth-Quarter and Full-Year 2014 Earnings Conference Call investment picks
2015/1/16
NEW YORK, Jan.
Sign-up for Hudson Global Amends Rights Agreement to Protect Its Net Operating Losses investment picks
2015/1/16
ROCKVILLE, Md.
Sign-up for CASI Pharmaceuticals Highlights 2014 Accomplishments And 2015 Milestones investment picks
2015/1/16
Garmin International Inc., a unit of Garmin Ltd.
Sign-up for Garmin® Introduces New GNX™ 7- and 10-Inch Marine Instruments investment picks
2015/1/16
JACKSONVILLE, Fla., Jan.
Sign-up for ParkerVision Closes Previously Announced Sale of Warrants investment picks
2015/1/16
Reports Fourth Quarter Net Income of $1.1 Billion and $1.84 Diluted EPS Loans, Deposits and Capital Grow, Expenses Controlled PITTSBURGH , Jan.
Sign-up for PNC Earns Full Year 2014 Net Income Of $4.2 Billion And $7.30 Diluted EPS investment picks
2015/1/16
Full-Year 2014 Net Income of $593 Million, or $3.16 Per Share Broad-Based Loan and Deposit Growth Compared to Full-Year 2013 Average Loans Up $2.2 Billion, or 5 Percent Average Deposit Growth of $3.1 Billion, or 6 Percent Drive for Efficiency Demonstrated in Well-Controlled Expenses Credit Quality Remains Strong 5.2 Million Shares Repurchased in 2014 Under the Share Repurchase Program; $392 Million or 66 Percent of 2014 Net Income Returned to Shareholders DALLAS , Jan.
Sign-up for Comerica Reports Fourth Quarter 2014 Net Income Of $149 Million, Or 80 Cents Per Share investment picks
2015/1/16
By Barbara Kollmeyer, MarketWatch Critical information ahead of the stock market's open Back in the early '90s, while I was backpacking around Europe, Switzerland was just one of the places to cross off my bucket list.
Sign-up for What could get creamed as Swiss move snowballs investment picks
2015/1/16
AFFINITY Trial to Continue as Planned Following Completion of Interim Futility Analysis BOTHELL, Wash.
Sign-up for OncoGenex Announces Update on Phase 3 AFFINITY Trial Evaluating Custirsen in Men with Metastatic Castrate-Resistant Prostate Cancer investment picks
2015/1/16
(All amounts in US$ unless otherwise specified) VANCOUVER , Jan.
Sign-up for Capstone Mining Announces New $500 Million Corporate Credit Facility investment picks
2015/1/16
Consortia funded through the IMI Ebola+ Programme Supported by the European Commission Brings together London School of Hygiene and Tropical Medicine, INSERM, University of Oxford University, La Centre Muraz, Bavarian Nordic A/S, Vibalogics, the Grameen Foundation and World Vision of Ireland with Janssen Pharmaceutical Companies to help accelerate Ad26 - MVA Ebola vaccine development and patient education NEW BRUNSWICK, N.J. , Jan.
Sign-up for Johnson & Johnson Announces Formation of Ebola Vaccine Development Consortia, Gains Funding from Innovative Medicines Initiative investment picks
2015/1/16
By Mark Hulbert, MarketWatch There's a big discrepancy between spot and futures prices CHAPEL HILL, N.C. (MarketWatch) -- Crude-oil futures are telling a far different story than the spot price is.
Sign-up for UPDATE: Investors are looking at the wrong oil prices investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: UPDATE: Jim Chanos downbeat on Exxon, Caterpillar, Intel to UPDATE: Investors are looking at the wrong oil prices
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent